APVO.O (APVO.O) News
Follow APVO.O (APVO.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Aptevo spotlights tumor — targeted CD40 multispecific program at SITC 2026 meeting
Aptevo Therapeutics announced a presentation at the SITC 2026 Annual Meeting highlighting its CD40-directed multispecific cancer immunotherapy platform. Results have not been presented yet; the data are scheduled for Nov
NEWS | Oct 14, 2026, 12:55 PM UTC
L
Aptevo to present multispecific CD40 platform at SITC annual meeting
Aptevo will present its multispecific platform at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting on Nov. 4-8, 2026. The meeting is scheduled for the Phoenix Convention Center in Phoenix, Arizona. The
NEWS | Oct 14, 2026, 12:46 PM UTC